ABVC BioPharma, Inc. (NASDAQ: ABVC) ("ABVC" or the "Company"), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics and commercial ingredient platforms, today ...
BIO-key International (BKYI) announced on Wednesday that Nasdaq has flagged the company for non-compliance due to a delay in filing its Q1 2026 Form 10-Q for the period ended March 31, 2026. Nasdaq’s ...
Mr. DePasquale will highlight BIO-key’s growing success in high value sectors including Military & Defense, Finance, Government, and Higher Education, where its unique biometric solutions are solving ...
Detailed price information for Bio-Key International Inc (BKYI) from The Globe and Mail including charting and trades.
CommentaryBIO-key CEO, Mike DePasquale commented, “We had a very productive third quarter, with revenue increasing 18% year-over-year and $1M compared to Q2’24, supported by license fee revenue which ...
Earnings Call Insights: BIO-key International, Inc. (BKYI) Q3 2025 DePasquale stated, "we expect continuing deployments in orders even this quarter and beyond" with the large banking customer, ...
BIO-key (BKYI) International announced a strategic partnership with Guinn Partners, a provider of advanced engineering solutions for robotics, drones, and electric propulsion systems. The companies ...
BIO-key International ( (BKYI) ) just unveiled an announcement.
BIO-key ® International, Inc. (OTC Markets: BKYI), a provider of biometric authentication technologies used by leading military and defense ministries, announced that its CEO Michael DePasquale will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results